We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS WON'T CONSIDER APPEAL OF NIH DECISION ON NORVIR PATENT
HHS WON'T CONSIDER APPEAL OF NIH DECISION ON NORVIR PATENT
August 5, 2004
HHS Secretary Tommy Thompson will not overrule the National Institutes of Health’s (NIH’s) decision to deny a request by an advocacy group to break patents on Abbott Laboratories’ AIDS drug Norvir and authorize generic competition, an HHS official said yesterday.